Occupational exposures and chronic kidney disease: Possible associations with endotoxin and ultrafine particles

American Journal of Industrial Medicine

Volumn 59, Issue 1, 2016, Pages 1-11

  Sponholtz, Todd R ^a   Sandler, Dale P ^b   Parks, Christine G ^b   Applebaum, Katie M ^c,d  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Heavy metals; Kidney disease; Nephritis; Occupational exposures; Particulates; Silica

Indexed keywords

AIR POLLUTANT; DUST; ENDOTOXIN; METAL; PARTICULATE MATTER; SOLVENT;

ADVERSE EFFECTS; AIR POLLUTANT; ANIMAL HUSBANDRY; CASE CONTROL STUDY; CROP PRODUCTION; DUST; FEMALE; HUMAN; INDUSTRY; MALE; MIDDLE AGED; NORTH CAROLINA; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; ODDS RATIO; PARTICLE SIZE; PARTICULATE MATTER; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

AIR POLLUTANTS, OCCUPATIONAL; ANIMAL HUSBANDRY; CASE-CONTROL STUDIES; CROP PRODUCTION; DUST; ENDOTOXINS; FEMALE; HUMANS; INDUSTRY; LOGISTIC MODELS; MALE; METALS; MIDDLE AGED; NORTH CAROLINA; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; ODDS RATIO; PARTICLE SIZE; PARTICULATE MATTER; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; SOLVENTS;

EID: 84954360886     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.22541     Document Type: Article

References (61)

1. Almaguer M, Herrera R, Orantes CM. 2014. Chronic kidney disease of unknown etiology in agricultural communities. MEDICC Rev 16:9-15.
2. Archer JD, Cooper GS, Reist PC, Storm JF, Nylander-French LA. 2002. Exposure to respirable crystalline silica in eastern North Carolina farm workers. AIHA J 63:750-755.
3. Bello AK, Nwankwo E, El Nahas AM. 2005. Prevention of chronic kidney disease: a global challenge. Kidney Int S11-S17.
4. Boujemaa W, Lauwerys R, Bernard A. 1994. Early indicators of renal dysfunction in silicotic workers. Scand J Work Environ Health 20:180-183.
5. Calvert GM, Steenland K, Palu S. 1997. End-stage renal disease among silica-exposed gold miners. A new method for assessing incidence among epidemiologic cohorts. JAMA 277:1219-1223.
6. Carta P, Aru G, Manca P. 2001. Mortality from lung cancer among silicotic patients in Sardinia: an update study with 10 more years of follow up. Occup Environ Med 58:786-793.
7. Centers for Disease Control and Prevention. 2002. Health effects of occupational exposure to respirable crystalline silica. Department of Health and Human Services, National Institute for Occupational Safety and Health, Publication No. 2002-129.
8. Cherry N, Harris J, McDonald C, Turner S, Taylor TN, Cullinan P. 2013. Mortality in a cohort of Staffordshire pottery workers: follow-up to December 2008. Occup Environ Med 70:149-155.
9. Chowdhury R, Darrow L, McClellan W, Sarnat S, Steenland K. 2014. Incident ESRD among participants in a lead surveillance program. Am J Kidney Dis 64:25-31.
10. Colt JS, Engel LS, Keifer MC, Thompson ML, Zahm SH. 2001. Comparability of data obtained from migrant farmworkers and their spouses on occupational history. Am J Ind Med 40:523-530.
11. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. 2007. Prevalence of chronic kidney disease in the United States. JAMA 298:2038-2047.
12. Ehrlich R, Robins T, Jordaan E, Miller S, Mbuli S, Selby P, Wynchank S, Cantrell A, De Broe M, D'Haese P, et al. 1998. Lead absorption and renal dysfunction in a South African battery factory. Occup Environ Med 55:453-460.
13. Friesen MC, Costello S, Thurston SW, Eisen EA. 2011. Distinguishing the common components of oil- and water-based metalworking fluids for assessment of cancer incidence risk in autoworkers. Am J Ind Med 54:450-460.
14. Garcon G, Leleu B, Zerimech F, Marez T, Haguenoer JM, Furon D, Shirali P. 2004. Biologic markers of oxidative stress and nephrotoxicity as studied in biomonitoring of adverse effects of occupational exposure to lead and cadmium. J Occup Environ Med 46:1180-1186.
15. Gonzalez-Yebra AL, Kornhauser C, Wrobel K, Perez-Luque EL, Wrobel K, Barbosa G. 2006. Occupational exposure to toluene and its possible causative role in renal damage development in shoe workers. Int Arch Occup Environ Health 79:259-264.
16. Gregorini G, Ferioli A, Donato F, Tira P, Morassi L, Tardanico R, Lancini L, Maiorca R. 1993. Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: a hospital-based case-control study. Adv Exp Med Biol 336:435-440.
17. Hotz P, Gonzalez-Lorenzo J, Siles E, Trujillano G, Lauwerys R, Bernard A. 1995. Subclinical signs of kidney dysfunction following short exposure to silica in the absence of silicosis. Nephron 70:438-442.
18. Jacob S, Hery M, Protois JC, Rossert J, Stengel B. 2007. New insight into solvent-related end-stage renal disease: occupations, products and types of solvents at risk. Occup Environ Med 64:843-848.
19. Landrigan PJ, Goyer RA, Clarkson TW, Sandler DP, Smith JH, Thun MJ, Wedeen RP. 1984. The work-relatedness of renal disease. Arch Environ Health 39:225-230.
20. Lauwerys R, Bernard A, Viau C, Buchet JP. 1985. Kidney disorders and hematotoxicity from organic solvent exposure. Scand J Work Environ Health 11(Suppl 1):83-90.
21. Lerchen ML, Samet JM. 1986. An assessment of the validity of questionnaire responses provided by a surviving spouse. Am J Epidemiol 123:481-489.
22. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. 2009. A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604-612.
23. McDonald AD, McDonald JC, Rando RJ, Hughes JM, Weill H. 2001. Cohort mortality study of North American industrial sand workers. I. Mortality from lung cancer, silicosis and other causes. Ann Occup Hyg 45:193-199.
24. McDonald JC, McDonald AD, Hughes JM, Rando RJ, Weill H. 2005. Mortality from lung and kidney disease in a cohort of North American industrial sand workers: an update. Ann Occup Hyg 49:367-373.
25. Meyer BR, Fischbein A, Rosenman K, Lerman Y, Drayer DE, Reidenberg MM. 1984. Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. Am J Med 76:989-998.
26. Miserocchi G, Sancini G, Mantegazza F, Chiappino G. 2008. Translocation pathways for inhaled asbestos fibers. Environ Health 7:4.
27. Muntner P, He J, Vupputuri S, Coresh J, Batuman V. 2003. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney Int 63:1044-1050.
28. Muntner P, Menke A, DeSalvo KB, Rabito FA, Batuman V. 2005. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med 165:2155-2161.
29. Ng TP, Lee HS, Phoon WH. 1993. Further evidence of human silica nephrotoxicity in occupationally exposed workers. Br J Ind Med 50:907-912.
30. Nolan CV, Shaikh ZA. 1992. Lead nephrotoxicity and associated disorders: biochemical mechanisms. Toxicology 73:127-146.
31. Nuyts GD, Van Vlem E, Thys J, De Leersnijder D, D'Haese PC, Elseviers MM, De Broe ME. 1995. New occupational risk factors for chronic renal failure. Lancet 346:7-11.
32. Nwankwo E, Bello AK, El Nahas AM. 2005. Chronic kidney disease: stemming the global tide. Am J Kidney Dis 45:201-208.
33. Parks CG, Conrad K, Cooper GS. 1999. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 107(Suppl 5):793-802.
34. Parks CG, Cooper GS, Nylander-French LA, Storm JF, Archer JD. 2003. Assessing exposure to crystalline silica from farm work: a population-based study in the Southeastern United States. Ann Epidemiol 13:385-392.
35. Pfaller W, Gstraunthaler G. 1998. Nephrotoxicity testing in vitro-what we know and what we need to know. Environ Health Perspect 106(Suppl 2):559-569.
36. Pfau JC, Sentissi JJ, Li S, Calderon-Garciduenas L, Brown JM, Blake DJ. 2008. Asbestos-induced autoimmunity in C57BL/6 mice. J Immunotoxicol 5:129-137.
37. Radican L, Wartenberg D, Rhoads GG, Schneider D, Wedeen R, Stewart P, Blair A. 2006. A retrospective occupational cohort study of end-stage renal disease in aircraft workers exposed to trichloroethylene and other hydrocarbons. J Occup Environ Med 48:1-12.
38. Rapiti E, Sperati A, Miceli M, Forastiere F, Di Lallo D, Cavariani F, Goldsmith DF, Perucci CA. 1999. End stage renal disease among ceramic workers exposed to silica. Occup Environ Med 56:559-561.
39. Sabolic I. 2006. Common mechanisms in nephropathy induced by toxic metals. Nephron Physiol 104:107-114.
40. Saldana TM, Basso O, Darden R, Sandler DP. 2007. Carbonated beverages and chronic kidney disease. Epidemiology 18:501-506.
41. Sandler DP, Smith JC, Weinberg CR, Buckalew VM, Jr., Dennis VW, Blythe WB, Burgess WP. 1989. Analgesic use and chronic renal disease. N Engl J Med 320:1238-1243.
42. Shannahan JH, Kodavanti UP, Brown JM. 2012. Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells. Inhal Toxicol 24:320-339.
43. Soderland P, Lovekar S, Weiner DE, Brooks DR, Kaufman JS. 2010. Chronic kidney disease associated with environmental toxins and exposures. Adv Chronic Kidney Dis 17:254-264.
44. Soll-Johanning H, Hannerz H. 2002. A validation of information on occupation-data from a nested case-control study. Int Arch Occup Environ Health 75:511-514.
45. Staessen JA, Lauwerys RR, Buchet JP, Bulpitt CJ, Rondia D, Vanrenterghem Y, Amery A. 1992. Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N Engl J Med 327:151-156.
46. Steenland NK, Thun MJ, Ferguson CW, Port FK. 1990. Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health 80:153-157.
47. Steenland K, Nowlin S, Ryan B, Adams S. 1992. Use of multiple-cause mortality data in epidemiologic analyses: US rate and proportion files developed by the National Institute for Occupational Safety and Health and the National Cancer Institute. Am J Epidemiol 136:855-862.
48. Steenland K, Sanderson W, Calvert GM. 2001. Kidney disease and arthritis in a cohort study of workers exposed to silica. Epidemiology 12:405-412.
49. Steenland K, Rosenman K, Socie E, Valiante D. 2002. Silicosis and end-stage renal disease. Scand J Work Environ Health 28:439-442.
50. Steenland K, Burnett C, Lalich N, Ward E, Hurrell J. 2003. Dying for work: The magnitude of US mortality from selected causes of death associated with occupation. Am J Ind Med 43:461-482.
51. Steenland K. 2005. One agent, many diseases: exposure-response data and comparative risks of different outcomes following silica exposure. Am J Ind Med 48:16-23.
52. Tsaih SW, Korrick S, Schwartz J, Amarasiriwardena C, Aro A, Sparrow D, Hu H. 2004. Lead, diabetes, hypertension, and renal function: the normative aging study. Environ Health Perspect 112:1178-1182.
53. US Census Bureau. 1980 Census of population: Alphabetical Index of Industries and Occupations. Washington, D.C.: US Bureau for the Census. 1980.
54. US Renal Data System. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States.
55. Vupputuri S, Sandler DP. 2003. Lifestyle risk factors and chronic kidney disease. Ann Epidemiol 13:712-720.
56. Vupputuri S, Parks CG, Nylander-French LA, Owen-Smith A, Hogan SL, Sandler DP. 2012. Occupational silica exposure and chronic kidney disease. Ren Fail 34:40-46.
57. Wang VS, Lee MT, Chiou JY, Guu CF, Wu CC, Wu TN, Lai JS. 2002. Relationship between blood lead levels and renal function in lead battery workers. Int Arch Occup Environ Health 75:569-575.
58. Weaver VM, Griswold M, Todd AC, Jaar BG, Ahn KD, Thompson CB, Lee BK. 2009. Longitudinal associations between lead dose and renal function in lead workers. Environ Res 109:101-107.
59. Weiner DE, McClean MD, Kaufman JS, Brooks DR. 2013. The Central American epidemic of CKD. Clin J Am Soc Nephrol 8:504-511.
60. World Health Organization. 2000. Crystaline silica, quartz. Report No.: Document 24.
61. Zheng D, Cao Q, Lee VW, Wang Y, Zheng G, Wang Y, Tan TK, Wang C, Alexander SI, Harris DC, et al. 2012. Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease. Kidney Int 81:892-902.